Suppr超能文献

Application of quality by design in the control of adventitious viruses: gaps in current processes in the prevention of virus contaminants.

作者信息

Cherney Barry

机构信息

Deputy Director, Division of Therapeutic Proteins, CDER, FDA.

出版信息

PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):754-66. doi: 10.5731/pdajpst.2011.00849.

Abstract

CONFERENCE PROCEEDING Proceedings of the PDA/FDA Adventitious Viruses in Biologics: Detection and Mitigation Strategies Workshop in Bethesda, MD, USA; December 1-3, 2010 Guest Editors: Arifa Khan (Bethesda, MD), Patricia Hughes (Bethesda, MD) and Michael Wiebe (San Francisco, CA).

摘要

相似文献

2
Current European regulations for control of adventitious virus safety.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):568-79. doi: 10.5731/pdajpst.2011.00821.
3
Introduction to workshop: adventitious viruses in biologics--detection and mitigation strategies.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):544-6. doi: 10.5731/pdajpst.2011.00817.
5
A microarray platform for virus detection and identification.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):691. doi: 10.5731/pdajpst.2011.00839.
6
Overview of emerging technologies to detect adventitious agents.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):654-9. doi: 10.5731/pdajpst.2011.00834.
7
Viral Safety of Plasma-derived Products.血浆衍生产品的病毒安全性。
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):737-53. doi: 10.5731/pdajpst.2011.00848.
8
Summary of breakout session e.分组会议E总结
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):616-9. doi: 10.5731/pdajpst.2011.00828.
9
Summary of Breakout Session B: Regulatory Expectations for CGMP.
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):713-4. doi: 10.5731/pdajpst.2011.00847.
10
Use of DOP-PCR in Non-Specific Virus Detection.巢式聚合酶链反应在非特异性病毒检测中的应用。
PDA J Pharm Sci Technol. 2011 Nov-Dec;65(6):681-4. doi: 10.5731/pdajpst.2011.00842.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验